Wenmin Yuan

2.8k total citations
53 papers, 2.2k citations indexed

About

Wenmin Yuan is a scholar working on Molecular Biology, Biomaterials and Surgery. According to data from OpenAlex, Wenmin Yuan has authored 53 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Biomaterials and 10 papers in Surgery. Recurrent topics in Wenmin Yuan's work include Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Wenmin Yuan is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), RNA Interference and Gene Delivery (11 papers) and Advanced biosensing and bioanalysis techniques (8 papers). Wenmin Yuan collaborates with scholars based in United States, China and Germany. Wenmin Yuan's co-authors include Anna Schwendeman, Rui Kuai, James J. Moon, Yao Xu, Jie Tang, Zhirong Zhang, Yao Qin, Minzhi Yu, Huali Chen and Jutaek Nam and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Journal of Controlled Release.

In The Last Decade

Wenmin Yuan

52 papers receiving 2.2k citations

Peers

Wenmin Yuan
Jing Qi China
Jan A. A. M. Kamps Netherlands
Vladimir V. Shuvaev United States
Jie Tang China
Vibhudutta Awasthi United States
Shyam S. Bansal United States
Qin Lu China
Jing Qi China
Wenmin Yuan
Citations per year, relative to Wenmin Yuan Wenmin Yuan (= 1×) peers Jing Qi

Countries citing papers authored by Wenmin Yuan

Since Specialization
Citations

This map shows the geographic impact of Wenmin Yuan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenmin Yuan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenmin Yuan more than expected).

Fields of papers citing papers by Wenmin Yuan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenmin Yuan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenmin Yuan. The network helps show where Wenmin Yuan may publish in the future.

Co-authorship network of co-authors of Wenmin Yuan

This figure shows the co-authorship network connecting the top 25 collaborators of Wenmin Yuan. A scholar is included among the top collaborators of Wenmin Yuan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenmin Yuan. Wenmin Yuan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Wenmin, et al.. (2024). Mining Spatial-Temporal Frequent Patterns of Natural Disasters in China Based on Textual Records. Information. 15(7). 372–372. 1 indexed citations
2.
Yu, Minzhi, Yayuan Liu, Wenmin Yuan, et al.. (2024). Development of an Accelerated Rotator-based Drug Release Method for the Evaluation of Bupivacaine Multivesicular Liposomes. Pharmaceutical Research. 41(2). 293–303. 2 indexed citations
3.
Sun, Hao, Shu Wang, Yunqiang Zhu, Wenmin Yuan, & Zhiqiang Zou. (2023). Question Classification for Intelligent Question Answering: A Comprehensive Survey. ISPRS International Journal of Geo-Information. 12(10). 415–415. 1 indexed citations
4.
Yu, Minzhi, Wenmin Yuan, Yayuan Liu, et al.. (2023). Characterization of exparel bupivacaine multivesicular liposomes. International Journal of Pharmaceutics. 639. 122952–122952. 21 indexed citations
5.
Pan, Ting, Wenmin Yuan, Xiaochun Liu, et al.. (2023). Novel ProTide prodrugs of 5-fluoro-2′-deoxyuridine for the treatment of liver cancer. European Journal of Medicinal Chemistry. 260. 115763–115763. 1 indexed citations
6.
Yuan, Wenmin, Rui Kuai, Emily E. Morin, et al.. (2022). Systematic evaluation of the effect of different apolipoprotein A-I mimetic peptides on the performance of synthetic high-density lipoproteins in vitro and in vivo. Nanomedicine Nanotechnology Biology and Medicine. 48. 102646–102646. 10 indexed citations
7.
Jiang, Ying, et al.. (2021). The role of IP-10 and its receptor CXCR3 in early pregnancy. Molecular Immunology. 140. 59–69. 14 indexed citations
8.
Liu, Yayuan, Zihan Mei, Ling Mei, et al.. (2020). Analytical method development and comparability study for AmBisome® and generic Amphotericin B liposomal products. European Journal of Pharmaceutics and Biopharmaceutics. 157. 241–249. 19 indexed citations
9.
Morin, Emily E., Yanhong Guo, Hongliang He, et al.. (2020). Synergetic Effect of rHDL and LXR Agonist on Reduction of Atherosclerosis in Mice. Frontiers in Pharmacology. 11. 513031–513031. 11 indexed citations
10.
Manthei, Kelly A., Dhabaleswar Patra, Christopher J. Wilson, et al.. (2020). Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles. Communications Biology. 3(1). 28–28. 34 indexed citations
11.
Patel, Hiren, Bei Ding, Lei Shen, et al.. (2019). Characterization of apolipoprotein A-I peptide phospholipid interaction and its effect on HDL nanodisc assembly. Dove Medical Press (Taylor and Francis Group). 1 indexed citations
12.
Yu, Minzhi, Wenmin Yuan, Dan Li, Anna Schwendeman, & Steven P. Schwendeman. (2019). Predicting drug release kinetics from nanocarriers inside dialysis bags. Journal of Controlled Release. 315. 23–30. 145 indexed citations
13.
Manthei, Kelly A., Shyh‐Ming Yang, Bolormaa Baljinnyam, et al.. (2018). Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol. eLife. 7. 31 indexed citations
14.
Kuai, Rui, Xiaoqi Sun, Wenmin Yuan, et al.. (2018). Dual TLR agonist nanodiscs as a strong adjuvant system for vaccines and immunotherapy. Journal of Controlled Release. 282. 131–139. 110 indexed citations
15.
Tang, Jie, Dan Li, Lindsey Drake, et al.. (2016). Influence of route of administration and lipidation of apolipoprotein A-I peptide on pharmacokinetics and cholesterol mobilization. Journal of Lipid Research. 58(1). 124–136. 27 indexed citations
16.
Yuan, Wenmin, Rui Kuai, Zhipeng Dai, et al.. (2016). Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes. The AAPS Journal. 19(1). 150–160. 34 indexed citations
17.
Smith, Carolyne K., Nickie Seto, Anuradha Vivekanandan‐Giri, et al.. (2016). Lupus high-density lipoprotein induces proinflammatory responses in macrophages by binding lectin-like oxidised low-density lipoprotein receptor 1 and failing to promote activating transcription factor 3 activity. Annals of the Rheumatic Diseases. 76(3). 602–611. 51 indexed citations
18.
Sang, Zhipei, Xiaoming Qiang, Yan Li, et al.. (2015). Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 94. 348–366. 80 indexed citations
19.
Qin, Yao, Huali Chen, Qianyu Zhang, et al.. (2011). Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. International Journal of Pharmaceutics. 420(2). 304–312. 109 indexed citations
20.
He, Qin, et al.. (2007). Study on in vivo distribution of liver-targeting nanopaticles encapsulating thymidine kinase gene (TK gene) in mice. Journal of Materials Science Materials in Medicine. 19(2). 559–565. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026